$XELB
XCel Brands, Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024012121 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.912M $2.954M
YoY Change -27.49% -56.44%
Cost Of Revenue $407.0K $38.00K
YoY Change 80.89% -99.0%
Gross Profit $1.505M $2.916M
YoY Change -37.6% -2.18%
Gross Profit Margin 78.71% 98.71%
Selling, General & Admin $1.618M $1.490M
YoY Change -53.53% -49.37%
% of Gross Profit 107.51% 51.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $910.0K $1.545M
YoY Change -45.74% -13.49%
% of Gross Profit 60.47% 52.98%
Operating Expenses $1.618M $1.490M
YoY Change -53.53% -49.37%
Operating Profit -$9.078M $307.0K
YoY Change 68.02% -108.28%
Interest Expense -$703.0K
YoY Change 38.39%
% of Operating Profit -228.99%
Other Income/Expense, Net
YoY Change
Pretax Income -$9.220M $161.0K
YoY Change 70.65% -104.35%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$9.213M $195.0K
YoY Change 79.1% -105.62%
Net Earnings / Revenue -481.85% 6.6%
Basic Earnings Per Share -$0.39 $0.01
Diluted Earnings Per Share -$0.39 $0.01
COMMON SHARES
Basic Shares Outstanding 23.51M 23.49M
Diluted Shares Outstanding 23.52M 23.54M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $924.0K
YoY Change -73.65%
Cash & Equivalents $200.0K $900.0K
Short-Term Investments
Other Short-Term Assets $378.0K
YoY Change -31.77%
Inventory $407.0K
Prepaid Expenses
Receivables $2.908M $3.055M
Other Receivables $0.00
Total Short-Term Assets $3.525M $4.764M
YoY Change -57.95% -59.41%
LONG-TERM ASSETS
Property, Plant & Equipment $202.0K $214.0K
YoY Change -74.07% -76.64%
Goodwill
YoY Change
Intangibles $35.64M $36.53M
YoY Change -17.22% -18.07%
Long-Term Investments $9.796M $16.64M
YoY Change -44.5% -8.38%
Other Assets $911.0K $920.0K
YoY Change 1114.67% 3580.0%
Total Long-Term Assets $50.47M $58.41M
YoY Change -25.08% -16.26%
TOTAL ASSETS
Total Short-Term Assets $3.525M $4.764M
Total Long-Term Assets $50.47M $58.41M
Total Assets $54.00M $63.17M
YoY Change -28.71% -22.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.353M
YoY Change -14.44%
Accrued Expenses $1.354M
YoY Change -1.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.000M $1.000M
YoY Change
Total Short-Term Liabilities $6.783M $6.068M
YoY Change 1.91% -13.31%
LONG-TERM LIABILITIES
Long-Term Debt $3.297M $3.524M
YoY Change
Other Long-Term Liabilities $431.0K $430.0K
YoY Change -96.88% -96.9%
Total Long-Term Liabilities $12.25M $13.03M
YoY Change -11.14% -6.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.783M $6.068M
Total Long-Term Liabilities $12.25M $13.03M
Total Liabilities $19.03M $19.10M
YoY Change -6.89% -8.46%
SHAREHOLDERS EQUITY
Retained Earnings -$69.20M -$59.90M
YoY Change 46.92% 42.96%
Common Stock $24.00K $23.00K
YoY Change 20.0% 15.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.92M $46.02M
YoY Change
Total Liabilities & Shareholders Equity $54.00M $63.17M
YoY Change -28.71% -22.48%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$9.213M $195.0K
YoY Change 79.1% -105.62%
Depreciation, Depletion And Amortization $910.0K $1.545M
YoY Change -45.74% -13.49%
Cash From Operating Activities -$274.0K
YoY Change -118.98%
INVESTING ACTIVITIES
Capital Expenditures $104.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$104.0K
YoY Change -123.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -250.0K
YoY Change
NET CHANGE
Cash From Operating Activities -274.0K
Cash From Investing Activities -104.0K
Cash From Financing Activities -250.0K
Net Change In Cash -628.0K
YoY Change -133.14%
FREE CASH FLOW
Cash From Operating Activities -$274.0K
Capital Expenditures $104.0K
Free Cash Flow -$378.0K
YoY Change -126.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001083220
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23492117
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19795053
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37527
dei Entity Registrant Name
EntityRegistrantName
XCEL BRANDS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0307819
dei Entity Address Address Line1
EntityAddressAddressLine1
550 Seventh Avenue, 11th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10018
dei City Area Code
CityAreaCode
347
dei Local Phone Number
LocalPhoneNumber
727-2474
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
XELB
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23507126
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
924000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2998000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3055000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3454000
CY2024Q2 us-gaap Inventory Net
InventoryNet
407000
CY2023Q4 us-gaap Inventory Net
InventoryNet
453000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
378000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
398000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
4764000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
7303000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
214000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
634000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4099000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4453000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
36532000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41520000
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
16643000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17735000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
920000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
58408000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
64357000
CY2024Q2 us-gaap Assets
Assets
63172000
CY2023Q4 us-gaap Assets
Assets
71660000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2353000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2236000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
989000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
889000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
372000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
372000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1354000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1258000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
964000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6068000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6469000
CY2024Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3111000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3556000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5964000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4021000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3524000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3971000
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
5432000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
430000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
40000
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
13029000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
17020000
CY2024Q2 us-gaap Liabilities
Liabilities
19097000
CY2023Q4 us-gaap Liabilities
Liabilities
23489000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23492117
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19795053
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
23000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
20000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
105946000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
103861000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59948000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53849000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
46021000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
50032000
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-1946000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-1861000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44075000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48171000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63172000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71660000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2954000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6781000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5138000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12831000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3800000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6493000
CY2024Q2 us-gaap Gross Profit
GrossProfit
2916000
CY2023Q2 us-gaap Gross Profit
GrossProfit
2981000
us-gaap Gross Profit
GrossProfit
5100000
us-gaap Gross Profit
GrossProfit
6338000
CY2024Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1630000
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2241000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3563000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
5706000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1490000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2943000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3519000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6436000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
3120000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
5184000
us-gaap Costs And Expenses
CostsAndExpenses
7082000
us-gaap Costs And Expenses
CostsAndExpenses
12142000
CY2024Q2 xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-204000
CY2023Q2 xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-2203000
xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-1982000
xelb Operating Income Loss Before Other Expense
OperatingIncomeLossBeforeOtherExpense
-5804000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1545000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1786000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3134000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3583000
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1188000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3483000
CY2024Q2 xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
557000
CY2023Q2 xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
515000
xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
1090000
xelb Loss From Equity Method Investments
LossFromEquityMethodInvestments
1030000
CY2024Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3801000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3801000
CY2023Q2 xelb Gain Loss On Sale Of Limited Partner Ownership Interest
GainLossOnSaleOfLimitedPartnerOwnershipInterest
351000
xelb Gain Loss On Sale Of Limited Partner Ownership Interest
GainLossOnSaleOfLimitedPartnerOwnershipInterest
351000
CY2023Q2 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
445000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
445000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
307000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3708000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5888000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9621000
CY2024Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-146000
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-296000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-18000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
161000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3701000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6184000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9639000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
161000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3701000
us-gaap Profit Loss
ProfitLoss
-6184000
us-gaap Profit Loss
ProfitLoss
-9639000
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-34000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-233000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-85000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-528000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
195000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3468000
us-gaap Net Income Loss
NetIncomeLoss
-6099000
us-gaap Net Income Loss
NetIncomeLoss
-9111000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23491238
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19735500
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21933079
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19684630
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23539886
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19735500
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21933079
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19684630
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
70139000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
51000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5938000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64258000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3701000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
60623000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48171000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36000
CY2024Q1 xelb Contra Revenue From Warrant Exercises
ContraRevenueFromWarrantExercises
10000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-6345000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
43872000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
161000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44075000
us-gaap Profit Loss
ProfitLoss
-6184000
us-gaap Profit Loss
ProfitLoss
-9639000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3134000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3583000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
3483000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
54000
us-gaap Share Based Compensation
ShareBasedCompensation
186000
us-gaap Share Based Compensation
ShareBasedCompensation
122000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-45000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1090000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1030000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
3801000
xelb Gain Loss On Sale Of Limited Partner Ownership Interest
GainLossOnSaleOfLimitedPartnerOwnershipInterest
351000
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
445000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-444000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1768000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-46000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2047000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
146000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-863000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-345000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5041000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-555000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1637000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-634000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-417000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
390000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2883000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1471000
xelb Net Proceeds From Sale Of Majority Interest In Investing Activity
NetProceedsFromSaleOfMajorityInterestInInvestingActivity
451000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
104000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
81000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
370000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1902000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
250000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1652000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1335000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1101000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2998000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4608000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1663000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3507000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
924000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3507000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
739000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1663000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3507000
xelb Operating Lease Right Of Use Asset Non Cash
OperatingLeaseRightOfUseAssetNonCash
2596000
xelb Operating Lease Liability Non Cash
OperatingLeaseLiabilityNonCash
2596000
us-gaap Interest Paid Net
InterestPaidNet
234000
us-gaap Income Taxes Paid
IncomeTaxesPaid
16000
us-gaap Net Income Loss
NetIncomeLoss
-6100000
us-gaap Other Noncash Expense
OtherNoncashExpense
7700000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2900000
CY2024Q2 xelb Working Capital Net
WorkingCapitalNet
1100000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
900000
CY2023 xelb Reduction In Payroll Costs Over Next Year
ReductionInPayrollCostsOverNextYear
6000000
CY2023 xelb Reduction In Operating Expenses Over Next Year
ReductionInOperatingExpensesOverNextYear
9000000
xelb Operating Expense Run Rate
OperatingExpenseRunRate
12500000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5000000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1900000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
59009000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22477000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36532000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
69309000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27789000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41520000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1520000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1540000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3060000.00
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3070000.00
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
200000
us-gaap Sublease Income
SubleaseIncome
300000
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
400000
us-gaap Operating Lease Payments
OperatingLeasePayments
800000
us-gaap Operating Lease Payments
OperatingLeasePayments
800000
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y11M19D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0771
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-10-30
CY2024Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0960
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
776000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1926000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2060000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1841000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
570000
CY2024Q2 xelb Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
2004000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9177000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1859000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7318000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1354000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5964000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4750000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5000000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
226000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
279000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
4524000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
4721000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
750000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3524000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3971000
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
140000
us-gaap Interest Expense Debt
InterestExpenseDebt
290000
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.116
CY2024Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.116
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
195000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3468000
us-gaap Net Income Loss
NetIncomeLoss
-6099000
us-gaap Net Income Loss
NetIncomeLoss
-9111000
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23491238
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19735500
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21933079
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19684630
CY2024Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
291
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
48357
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23539886
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19735500
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21933079
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19684630
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5913712
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6235485
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6074777
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6235485
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Payments For Royalties
PaymentsForRoyalties
100000
CY2024Q2 us-gaap Payments For Royalties
PaymentsForRoyalties
100000
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
275000
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1188000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
195000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-012121-index-headers.html Edgar Link pending
0001558370-24-012121-index.html Edgar Link pending
0001558370-24-012121.txt Edgar Link pending
0001558370-24-012121-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xelb-20240630.xsd Edgar Link pending
xelb-20240630x10q.htm Edgar Link pending
xelb-20240630xex31d1.htm Edgar Link pending
xelb-20240630xex31d2.htm Edgar Link pending
xelb-20240630xex32d1.htm Edgar Link pending
xelb-20240630xex32d2.htm Edgar Link pending
xelb-20240630_cal.xml Edgar Link unprocessable
xelb-20240630_def.xml Edgar Link unprocessable
xelb-20240630_lab.xml Edgar Link unprocessable
xelb-20240630_pre.xml Edgar Link unprocessable
xelb-20240630x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable